BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29537858)

  • 1. Evaluation of Practice Changes in the Care of Patients with Septic Shock during the U.S. Norepinephrine Shortage.
    Wunsch H; Hua M; Walkey AJ; Rubenfeld G; Vail E; Gershengorn HB
    Ann Am Thorac Soc; 2018 Apr; 15(4):509-511. PubMed ID: 29537858
    [No Abstract]   [Full Text] [Related]  

  • 2. Norepinephrine Shortage Led to Increased Deaths from Septic Shock.
    Stockwell S
    Am J Nurs; 2017 Jul; 117(7):15. PubMed ID: 28644271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
    Vail E; Gershengorn HB; Hua M; Walkey AJ; Rubenfeld G; Wunsch H
    JAMA; 2017 Apr; 317(14):1433-1442. PubMed ID: 28322415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice Patterns and Outcomes Associated With Choice of Initial Vasopressor Therapy for Septic Shock.
    Fawzy A; Evans SR; Walkey AJ
    Crit Care Med; 2015 Oct; 43(10):2141-6. PubMed ID: 26079345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS).
    Jeon K; Song JU; Chung CR; Yang JH; Suh GY
    Crit Care; 2018 May; 22(1):131. PubMed ID: 29784057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of norepinephrine on the outcome of septic shock.
    Martin C; Viviand X; Leone M; Thirion X
    Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressor administration and sepsis: a survey of Canadian intensivists.
    Lamontagne F; Cook DJ; Adhikari NKJ; Briel M; Duffett M; Kho ME; Burns KEA; Guyatt G; Turgeon AF; Zhou Q; Meade MO
    J Crit Care; 2011 Oct; 26(5):532.e1-532.e7. PubMed ID: 21454040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2013 Nov; 62(5):534-535. PubMed ID: 23683544
    [No Abstract]   [Full Text] [Related]  

  • 10. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
    Russell JA; Lee T; Singer J; Boyd JH; Walley KR;
    Crit Care Med; 2017 Jun; 45(6):940-948. PubMed ID: 28333757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin in septic shock: clinical equipoise mandates a time for restraint.
    Russell JA
    Crit Care Med; 2003 Nov; 31(11):2707-9. PubMed ID: 14605551
    [No Abstract]   [Full Text] [Related]  

  • 12. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence to Practice Gap: The Case of Dopamine.
    Annane D
    Crit Care Med; 2015 Oct; 43(10):2259-60. PubMed ID: 26376255
    [No Abstract]   [Full Text] [Related]  

  • 14. Terlipressin for norepinephrine-resistant septic shock.
    O'Brien A; Clapp L; Singer M
    Lancet; 2002 Apr; 359(9313):1209-10. PubMed ID: 11955542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
    Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
    J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early prediction of norepinephrine dependency and refractory septic shock with a multimodal approach of vascular failure.
    Conrad M; Perez P; Thivilier C; Levy B
    J Crit Care; 2015 Aug; 30(4):739-43. PubMed ID: 25900257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
    Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of vasopressor usage.
    Wolfe T; Dasta J; Reilley T; Flancbaum L
    Intensive Care Med; 1998 Aug; 24(8):890. PubMed ID: 9757938
    [No Abstract]   [Full Text] [Related]  

  • 19. Expanding the conversation regarding adjunctive corticosteroid therapy for pediatric septic shock.
    Zimmerman JJ
    Pediatr Crit Care Med; 2013 Jun; 14(5):541-3. PubMed ID: 23867432
    [No Abstract]   [Full Text] [Related]  

  • 20. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
    Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
    J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.